Design (Testphase)
Momentum & Trend
Qullamaggie: Top Gainers 1M
31
Hits
July 21, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 25 hits from US
Kullamägi's biggest-gainers screen over 1 month — exactly per his original filters: 1-month Absolute Strength rating (AS) > 97, i.e. the strongest roughly 3% of recent price gainers; plus ADR ≥ 3.5% (enough inherent movement) and average dollar volume over the last 20 days > $1.5M (liquid). He uses this scan to build his weekly watchlist of the hottest short-term names. Here, AS is our RS rating (percentile 1–99). Note: our universe is smaller than his, so expect fewer hits.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(19)
- Absolute Strength (AS)
- The strength rating from Qullamaggie's original tool: a percentile from 1 to 99 for price gains over a period (1, 3, or 6 months). On our site it corresponds to the RS Rating over the same period.
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Liquidity
- How easily a stock can be bought and sold without moving the price - measured by (dollar) volume. Illiquid stocks have wide spreads and jerky prices; that is why almost every scanner applies a minimum liquidity filter.
- Long / Short
- Long = betting on rising prices (buying the stock). Short = betting on falling prices (selling borrowed shares to buy them back cheaper later). Our short scanners are warning or watch lists - not buy candidates.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Relative Strength (RS Rating)
- How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DFTX Definium Therapeutics, Inc. | 07/30 | +332 % | — | Stage 2 | D -49 | 1 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 42.80 $ | +170.2 % | +246.6 % | +534.0 % | −4.7 % | +24.7 % | 98 | 50 | 14.0 % | 8.8 % | 2.21 | — | 0.0 | — | 21.3 | — | — | 0.0 | 0.0 % | — | 0.0 % | -94.7 % | -35.7 % | — | 69.5 % | — | 0.0 % | 0.0 % | 1.4 | 65.6 % | 9.8 % | — |
| HYLN Hyliion Holdings Corp. | 08/11 | +90 % | — | Stage 2 | C +9 | 4 of 9 | 0.0 | Auto Parts | Uses AI | — | Consumer Cyclical | 3.60 $ | +231.5 % | +141.9 % | +248.9 % | −42.8 % | +44.0 % | 98 | 50 | 13.6 % | 15.8 % | 3.47 | — | 0.0 | — | — | — | — | -0.8 | -481.7 % | 6.3 % | 0.0 % | -25.2 % | -17.5 % | — | 95.3 % | +130.3 % | 0.0 % | 0.0 % | 21.4 | 25.2 % | 7.6 % | 2.0 (1) | |
| ALOT AstroNova Inc | — | +30 % | 95 11/25 | Stage 2 | C +3 | 9 of 9 | 0.2 | Computer Hardware | – | — | — | Technology | 28.70 $ | +228.3 % | +249.6 % | +214.4 % | −0.8 % | -8.6 % | 98 | 81 | 8.8 % | 6.2 % | 0.86 | — | 14.0 | 1.5 | — | 22.1 | — | 38.6 | — | 33.8 % | -0.9 % | -1.8 % | 2.6 % | — | — | -0.5 % | 0.0 % | 0.0 % | 7.3 | 44.9 % | 0.2 % | — |
| WYY Widepoint C | 08/13 | +242 % | 92 10/25 | Stage 2 | C +3 | 5 of 9 | 0.2 | Information Technology Services | – | — | — | Technology | 11.60 $ | +184.4 % | +194.6 % | +459.4 % | −16.9 % | -3.5 % | 98 | 13 | 16.8 % | 12.9 % | 1.71 | — | 18.2 | 1.3 | — | 25.7 | 2.33 | 117.4 | — | 13.9 % | -1.2 % | -15.8 % | -1.6 % | — | — | +5.6 % | 0.0 % | 0.0 % | -0.1 | 18.7 % | 3.5 % | — |
| MBX MBX Biosciences, Inc. Common Stock | 08/06 | — | 69 6/22 | Stage 2 | D -33 | 3 of 9 | 2.3 | Biotechnology | – | — | — | Healthcare | 60.10 $ | +47.1 % | +67.7 % | +397.4 % | −4.1 % | +37.2 % | 97 | 42 | 8.5 % | 7.7 % | — | — | 0.0 | — | 5.5 | — | — | 0.0 | 0.0 % | — | 0.0 % | -25.7 % | -17.7 % | 0.00 | 96.7 % | — | 0.0 % | 0.0 % | 37.2 | 111.5 % | 16.8 % | 1.0 (5) |
| AMPG Amplitech Group Inc | 08/13 | +19 % | 95 11/25 | Stage 2 | B +11 | 5 of 9 | 0.2 | Communication Equipment | – | — | — | Technology | 6.20 $ | +158.5 % | +129.7 % | +260.7 % | −31.0 % | +0.3 % | 97 | 2 | 14.2 % | 17.4 % | -0.26 | — | 19.2 | 6.4 | — | — | — | -8.2 | — | 27.5 % | -24.8 % | -15.9 % | -8.7 % | — | — | +165.0 % | 0.0 % | 0.0 % | 8.1 | 24.5 % | 32.7 % | — |
| OTLK OUTLOOK THERAPEUTICS INC | 08/13 | -32 % | 71 6/22 | Stage 3 | D -42 | 4 of 9 | 0.2 | Biotechnology | Uses AI | — | Healthcare | 1.40 $ | +7.6 % | -7.7 % | +0.0 % | −52.5 % | +241.6 % | 97 | 42 | 16.8 % | 20.7 % | 0.78 | — | 2.8 | 790.0 | — | — | — | -4.1 | — | -360.8 % | 0.0 % | -3.7 % | -184.8 % | — | — | +730.9 % | 0.0 % | 0.0 % | -116.1 | 6.9 % | 10.1 % | — | |
| APGE Apogee Therapeutics, Inc. Common S | 08/10 | — | 68 6/22 | Stage 2 | D -30 | 4 of 9 | 10.0 | Biotechnology | – | — | — | Healthcare | 134.20 $ | +76.0 % | +69.8 % | +220.9 % | −0.4 % | -1.6 % | 96 | 42 | 6.7 % | 6.5 % | 0.33 | — | 0.0 | — | 7.9 | — | — | 0.0 | 0.0 % | — | 0.0 % | -28.5 % | -19.0 % | 0.01 | 97.1 % | — | 0.0 % | 0.0 % | 40.3 | 131.6 % | 22.0 % | 1.0 (9) |
| TWST Twist Bioscience Corp | 08/03 | +131 % | 54 5/22 | Stage 2 | D -16 | 4 of 9 | 6.0 | Diagnostics & Research | – | — | — | Healthcare | 87.50 $ | +168.0 % | +192.9 % | +158.6 % | −1.8 % | -23.3 % | 96 | 42 | 7.7 % | 7.8 % | 2.12 | — | 0.0 | 14.7 | 13.7 | — | — | -35.3 | -34.9 % | 52.1 % | -19.9 % | -18.2 % | -12.9 % | 0.21 | 67.3 % | +20.3 % | 0.0 % | 0.0 % | -0.1 | 123.8 % | 36.4 % | 1.3 (12) |
| BLZE Backblaze Inc | 08/06 | +57 % | 62 6/25 | Stage 3 | B +16 | 5 of 9 | 0.8 | Software - Infrastructure | Uses AI | — | Technology | 13.20 $ | +150.2 % | +211.9 % | +134.3 % | −8.2 % | +2.1 % | 96 | 42 | 14.6 % | 9.7 % | 1.55 | — | 178.6 | 5.1 | — | 55.9 | — | 149.5 | — | 62.3 % | -15.0 % | -27.6 % | -5.2 % | — | — | +14.3 % | 0.0 % | 0.0 % | -0.3 | 48.9 % | 2.6 % | — | |
| APPS Digital Turbine Inc | 08/04 | -13 % | 92 10/25 | Stage 2 | B +29 | 6 of 9 | 1.3 | Software - Application | – | — | — | Technology | 8.30 $ | +85.2 % | +140.0 % | +97.7 % | −5.9 % | -13.9 % | 95 | 17 | 10.7 % | 12.7 % | 2.77 | — | 3.7 | 2.2 | — | 110.7 | 0.69 | 17.7 | — | 48.6 % | -6.7 % | -21.8 % | 2.6 % | — | — | +15.2 % | 0.0 % | 0.0 % | 0.9 | 66.7 % | 10.2 % | — |
| NVCT Nuvectis Pharma Inc | 08/04 | +1 % | 82 7/22 | Stage 2 | E -54 | 1 of 9 | 0.9 | Biotechnology | – | — | — | Healthcare | 18.00 $ | +132.5 % | +270.0 % | +207.5 % | −0.2 % | +4.8 % | 95 | 42 | 16.4 % | 9.8 % | -0.25 | — | 0.0 | — | — | — | — | -7.4 | — | — | 0.0 % | -154.4 % | -63.6 % | — | — | -100.0 % | 0.0 % | 0.0 % | -7.1 | 18.2 % | 10.1 % | — |
| TMCI Treace Medical Concepts Inc | 08/06 | -28 % | 40 4/22 | Stage 3 | D -35 | 4 of 9 | 0.3 | Medical Devices | Neutral | — | Healthcare | 4.20 $ | +83.3 % | +75.0 % | -28.1 % | −42.8 % | -10.1 % | 94 | 42 | 10.5 % | 9.8 % | 1.38 | — | 0.0 | 1.2 | 3.5 | — | — | -40.9 | — | 79.7 % | -29.4 % | -66.9 % | -17.9 % | 0.18 | — | +1.6 % | 0.0 % | 0.0 % | 0.4 | 57.1 % | 6.3 % | — | |
| MEC Mayville Engineering Co Inc | 08/04 | +51 % | 49 6/29 | Stage 2 | D -15 | 3 of 9 | 0.9 | Metal Fabrication | – | — | — | Industrials | 29.10 $ | +82.5 % | +96.1 % | +111.8 % | −3.3 % | -4.5 % | 94 | 1 | 5.2 % | 6.5 % | 1.22 | — | 22.1 | 1.6 | 4.1 | 61.2 | — | 37.1 | — | 10.7 % | -2.9 % | -6.8 % | -0.7 % | 0.10 | — | -6.0 % | 0.0 % | 0.0 % | 4.6 | 60.8 % | 5.0 % | — |
| QMCO Quantum Corporation | — | -32 % | 62 6/25 | Stage 2 | D -17 | 4 of 9 | 0.4 | Computer Hardware | Uses AI | — | — | Technology | 11.00 $ | +114.1 % | +60.8 % | +63.9 % | −30.0 % | +27.6 % | 94 | 42 | 14.0 % | 14.5 % | 2.96 | — | 1.9 | 1.4 | 0.1 | — | 0.77 | 236.9 | — | 36.9 % | -36.1 % | 0.0 % | -6.6 % | -0.04 | — | -12.1 % | 0.0 % | 0.0 % | -26.0 | 12.8 % | 7.0 % | — |
| ALNT Allient Inc. | 08/05 | +50 % | — | Stage 2 | B +19 | 7 of 9 | 0.0 | Electronic Components | Neutral | — | Technology | 86.60 $ | +78.9 % | +77.1 % | +183.8 % | −2.3 % | -27.8 % | 93 | 50 | 6.4 % | 6.4 % | 1.59 | 68.3 | 34.1 | — | 5.4 | — | — | 23.8 | 7.3 % | 32.9 % | 4.3 % | 8.2 % | 5.1 % | 0.65 | 53.0 % | +4.6 % | 0.2 % | 5.9 % | 8.4 | 78.8 % | 5.5 % | 1.3 (3) | |
| ULCC Frontier Group Holdings Inc | 08/04 | -7 % | 49 6/29 | Stage 2 | D -18 | 3 of 9 | 1.8 | Airlines | – | — | — | Industrials | 6.20 $ | +53.9 % | +55.0 % | +112.0 % | −4.1 % | -23.5 % | 92 | 52 | 7.3 % | 7.6 % | 2.57 | — | 13.9 | 0.5 | 7.7 | — | — | 100.0 | — | -2.0 % | -9.6 % | -92.4 % | -6.3 % | 23.64 | — | -1.4 % | 0.0 % | 0.0 % | 1.7 | 55.2 % | 41.0 % | — |
| FRD Friedman Industries Inc. Common Stock | 08/06 | +92 % | 86 8/23 | Stage 2 | B +31 | 4 of 9 | 0.2 | Steel | Neutral | — | Basic Materials | 34.00 $ | +72.9 % | +56.6 % | +110.1 % | −11.2 % | — | 92 | 82 | 6.9 % | 6.2 % | 1.56 | 12.5 | 14.4 | 0.4 | 1.6 | 170.7 | — | 9.8 | — | 13.4 % | 3.0 % | 13.8 % | 6.0 % | 0.67 | — | +45.5 % | 0.5 % | 5.9 % | 9.4 | 53.7 % | 2.1 % | — | |
| UMAC Unusual Machines, Inc. | 08/13 | — | 83 8/25 | Stage 2 | B +24 | 6 of 9 | 0.9 | Computer Hardware | – | — | — | Technology | 17.40 $ | +68.8 % | +47.1 % | +139.2 % | −45.3 % | +79.0 % | 92 | 42 | 10.2 % | 15.0 % | 14.79 | — | 84.7 | 52.4 | 2.7 | — | — | 0.0 | — | 35.2 % | -32.7 % | -3.3 % | -10.2 % | 0.01 | — | +101.2 % | 0.0 % | 0.0 % | 51.6 | 57.7 % | 13.1 % | — |
| CLPT Clearpoint Neuro Inc | 08/11 | +61 % | 40 4/22 | Stage 3 | D -13 | 4 of 9 | 0.5 | Medical Devices | Neutral | — | — | Healthcare | 15.10 $ | +35.5 % | +34.1 % | +58.3 % | −40.3 % | +57.8 % | 90 | 42 | 11.6 % | 9.0 % | 1.24 | — | 12.1 | 13.4 | 28.7 | — | 0.61 | -7.1 | — | 62.3 % | -71.6 % | -149.7 % | -25.0 % | 3.38 | — | +17.8 % | 0.0 % | 0.0 % | -3.1 | 50.6 % | 17.0 % | — |
| RZLT Rezolute Inc | — | +40 % | 89 8/22 | Stage 3 | D -36 | 5 of 9 | 0.5 | Biotechnology | – | — | — | Healthcare | 4.50 $ | +107.2 % | +86.1 % | +24.8 % | −56.1 % | +52.4 % | 90 | 42 | 7.8 % | 8.4 % | 0.55 | — | 0.0 | — | 4.2 | — | — | 0.0 | — | — | 0.0 % | -81.7 % | -48.7 % | 0.01 | — | — | 0.0 % | 0.0 % | 7.1 | 90.4 % | 21.6 % | — |
| CTRN Citi Trends Inc | — | +84 % | 33 5/31 | Stage 2 | B +48 | 9 of 9 | 0.5 | Apparel Retail | – | — | — | Consumer Cyclical | 65.70 $ | +48.9 % | +37.2 % | +111.8 % | −15.3 % | +29.8 % | 88 | 96 | 8.0 % | 8.5 % | 1.83 | — | 3.6 | 0.6 | — | 16.4 | 2.85 | 19.1 | — | 39.7 % | 1.4 % | 10.3 % | 0.0 % | — | — | +8.9 % | 0.0 % | 0.0 % | 6.0 | 98.9 % | 16.9 % | — |
| JRSH Jerash Holdings US Inc | 08/11 | +14 % | 65 8/31 | Stage 2 | C +8 | 7 of 9 | 0.1 | Apparel Manufacturing | – | — | — | Consumer Cyclical | 4.50 $ | +59.6 % | +65.2 % | +53.0 % | −16.6 % | +31.6 % | 86 | 21 | 14.0 % | 7.3 % | 1.00 | — | 6.5 | 0.3 | — | — | — | 5.4 | — | 16.1 % | 2.1 % | 5.7 % | 4.6 % | — | — | +14.0 % | 4.5 % | 71.4 % | 47.4 | 9.1 % | 1.4 % | — |
| CBRL Cracker Barrel Old Country Store | — | -14 % | 74 9/31 | Stage 2 | C +5 | 6 of 9 | 1.1 | Restaurants | – | — | — | Consumer Cyclical | 53.40 $ | +85.7 % | +107.4 % | -17.1 % | −32.8 % | -18.3 % | 81 | 91 | 6.3 % | 6.9 % | 1.19 | 46.0 | 109.9 | 0.3 | 2.5 | 18.1 | 1.56 | 13.9 | — | 31.6 % | 0.8 % | 5.6 % | -0.1 % | 2.35 | — | +0.4 % | 1.9 % | 1.8 % | 3.4 | 97.7 % | 45.0 % | — |
| WNC Wabash National Corporation | 07/24 | -16 % | 49 6/29 | Stage 2 | D -24 | 2 of 9 | 0.5 | Farm & Heavy Construction Ma | – | — | — | Industrials | 13.30 $ | +48.3 % | +56.9 % | +31.0 % | −0.6 % | +43.5 % | 78 | 97 | 9.6 % | 6.9 % | 1.42 | — | 8.6 | 0.4 | 1.8 | — | 0.73 | 2.0 | — | 2.8 % | -4.4 % | -17.8 % | -2.2 % | 1.66 | — | -20.8 % | 2.4 % | 6.3 % | 4.6 | 100.8 % | 9.4 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Kullamägi's biggest-gainers screen over 1 month — exactly per his original filters: 1-month Absolute Strength rating (AS) > 97, i.e. the strongest roughly 3% of recent price gainers; plus ADR ≥ 3.5% (enough inherent movement) and average dollar volume over the last 20 days > $1.5M (liquid). He uses this scan to build his weekly watchlist of the hottest short-term names. Here, AS is our RS rating (percentile 1–99).
All scanners are recalculated daily across the entire stock universe — most recently on 21. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 31 stocks pass this scanner's criteria (as of 21. July 2026). The 25 strongest hits are shown.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- 21-EMA Trend
- Above 21-EMA Pullback
- Above the 50- & 200-SMA
- Ameet Rai: Daily Liquidity
- CANSLIM Type RS
- Character Change (CC)
- Chris Perruna: Daily New Highs
- Chris Perruna: Within 15% of Highs
- Gary Antonacci: Dual Momentum (Stock Adaptation)
- High ADR (≥5%)
- Jeff Sun
- Kathy Donnelly: Liquid Movers Up
- Mark Minervini: Trend Criteria — 1 Month
- Mike Webster: Cross Fire
- Mike Webster: Down Days Tell Screen
- Mike Webster: Power Trend Leader
- Mike Webster: Swing Trading List
- Near 52-Week High
- Oliver Kell: 52 Week Highs
- Oliver Kell: Doublers
- Oliver Kell: Strength on Down Day
- Power Trend
- Qullamaggie: Top Gainers 3M
- Qullamaggie: Top Gainers 6M
- Qullamaggie: Trend Intensity (13/65)
- RS Leader (≥90)
- RS New Highs
- Richard Moglen: 1 Week Top Performers
- Richard Moglen: Gaps and Strong Moves
- Richard Moglen: Top Performers 3/6 Month
- Stage 2 Leader
- Stan Weinstein: Checklist
- Stan Weinstein: Stage 1
- Stan Weinstein: Stage 2
- Stan Weinstein: Stage 3
- Strength on Stress Days
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.